Apolipoprotein E (apoE) plays an important role in lipo protein metabolism and atherosclerosis. ApoE is produced and secreted predominantly by the liver ( 1 ), but it is also expressed in a variety of other tissues, including macrophages ( 2, 3 ). While loss of function of apoE in mice and in humans is associated with a proatherogenic lipoprotein profi le and increased atherogenesis ( 4, 5 ), overexpression of apoE in various models has been shown to protect against atherosclerotic lesion formation ( 6-11 ). Among other metabolic effects that are potentially antiatherogenic, apoE has been reported to promote cholesterol effl ux (12)(13)(14), and recent studies have suggested that lack of macrophage apoE might decrease overall reverse cholesterol transport (RCT) ( 15 ). However, the pool of macrophage-derived apoE represents a small fraction of total circulating apoE.The classic RCT pathway is a multistep process that involves i ) HDL-mediated effl ux of excess cholesterol from extrahepatic cells and most relevant for atherosclerosis lipid-laden macrophages in the arterial wall, ii ) uptake of HDL cholesterol into the liver, and iii ) excretion of HDL Abstract ApoE plays an important role in lipoprotein metabolism. This study investigated the effects of adenovirusmediated human apoE overexpression (AdhApoE3) on sterol metabolism and in vivo reverse cholesterol transport (RCT). In wild-type mice, AdhApoE3 resulted in decreased HDL cholesterol levels and a shift toward larger HDL in plasma, whereas hepatic cholesterol content increased ( P < 0.05). These effects were dependent on scavenger receptor class B type I (SR-BI) as confi rmed using SR-BI-defi cient mice. Kinetic studies demonstrated increased plasma HDL cholesteryl ester catabolic rates ( P < 0.05) and higher hepatic selective uptake of HDL cholesteryl esters in AdhApoE3-injected wild-type mice ( P < 0.01). However, biliary and fecal sterol output as well as in vivo macrophage-to-feces RCT studied with 3 H-cholesterol-loaded mouse macrophage foam cells remained unchanged upon human apoE overexpression. Similar results were obtained using hApoE3 overexpression in human CETP transgenic mice. However, blocking ABCA1-mediated cholesterol effl ux from hepatocytes in AdhApoE3-injected mice using probucol increased biliary cholesterol secretion ( P < 0.05), fecal neutral sterol excretion ( P < 0.05), and in vivo RCT ( P < 0.01), specifi cally within neutral sterols. These combined data demonstrate that systemic apoE overexpression increases i ) SR-BI-mediated selective uptake into the liver and ii ) ABCA1-mediated effl ux of RCTrelevant cholesterol from hepatocytes back to the plasma compartment, thereby resulting in unchanged fecal mass sterol excretion and overall in vivo RCT. -Annema, W., A. Dikkers, J. F. de Boer, T. Gautier, P. C. N. Rensen, D. J. Rader, and U. J. F. Tietge. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol effl ux to plasma. J. Lipid Res . 2012. 53: 929-940. 29 February 2012. Published, JLR Pap...